Ae Wealth Management LLC Roivant Sciences Ltd. Transaction History

Ae Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$9.08 - $11.62 $11,095 - $14,199	-1,222 Reduced 0.87%	139,502 $1.57 Million
Q1 2025 May 06, 2025	SELL	$10.09 - $12.08 $18,353 - $21,973	-1,819 Reduced 1.28%	140,724 $1.42 Million
Q4 2024 Feb 13, 2025	SELL	$11.16 - $12.71 $30,299 - $34,507	-2,715 Reduced 1.87%	142,543 $1.69 Million
Q3 2024 Nov 14, 2024	BUY	$10.17 - $12.5 $182,459 - $224,262	17,941 Added 14.09%	145,258 $1.68 Million
Q2 2024 Aug 12, 2024	BUY	$10.36 - $11.74 $1.32 Million - $1.49 Million	127,317 New	127,317 $1.35 Million

376

443M

6.03M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $14.3B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.